Table 2

Profile of injecting drug use and sexual practices

Manipur


Ukhrul

Chandel


Baseline

% (95% CI)

Follow-up

% (95% CI)

Baseline

% (95% CI)

Follow-up

% (95% CI)


Frequency of injecting in the last week

At least once daily

4-6 times a week

2-3 times a week

Only once

Don’t know / remember

36.2 (29.2 – 43.0)

17.7 (12.8 – 22.0)

34.0 (27.8 – 39.4)

10.9 (7.3 – 17.4)

1.2 (0.3 – 2.6)

58.1 (0.50 – 65.9)

10.7 (6.6 – 16.0)

18.2 (12.6 – 25.1)

12.6 (7.6 – 17.4)

0.3 (0.1 – 0.7)

96.1 (93.5 – 97.7)

0.7 (0.2 – 1.4)

1.5 (0.6 – 2.9)

1.8 (0.7 – 3.1)

--

75.6 (70.1 – 81.0)

5.4 (3.4 – 7.7)

8.5 (5.4 – 12.0)

10.5 (6.4 – 14.3)

--


Did NOT share needles / syringes during past month

59.6 (53.6 - 65.2)

91.2 (88.0 – 94.0)

96.3 (94.2 – 98.0)

95.3 (92.7 – 97.5)


Did NOT share needles / syringes at last injection

71.1 (66.4 – 76.0)

97.0 (95.1 – 98.2)

97.0 (95.4 – 98.4)

98.9 (97.9 – 99.7)


Drew up drug solutions from a common container at last injection

26.0 (22.1 – 30.9)

10.3 (6.9 – 13.9)

6.6 (4.5 – 8.8)

24.6 (19.1 – 29.9)


Number of female partners had sex with in the past 12 months

None

1

2-3

>3

3.8 (1.6 – 6.5)

34.4 (28.9 – 41.7)

37.3 (31.1 – 43.1)

24.5 (19.5 – 28.9)

12.7 (8.7 – 19.0)

40.3 (32.3 – 45.5)

22.5 (17.4 – 29.0)

24.5 (19.1 – 30.9)

9.6 (6.4 – 13.1)

73.6 (66.7 – 78.1)

11.6 (8.3 – 16.4)

5.2 (2.8 – 8.8)

20.3 (16.7 – 25.9)

67.0 (60.9 – 72.3)

11.6 (7.3 – 15.2)

1.1 (0.4 – 1.9)


Condom use at last sex

Regular partner

Casual partner

40.5 (29.0 – 44.2)

60.2 (55.9 – 72.2)

48.0 (36.4 – 57.4)

80.7 (67.9 – 87.1)

34.7 (23.5 – 45.7)

57.4 (37.3 – 77.1)

27.4 (18.6 – 34.2)

63.6 (51.5 – 85.6)


STI symptoms during past 12 months

37.3 (32.5 – 41.9)

21.3 (16.4 – 25.8)

8.0 (5.8 – 10.6)

16.4 (12.5 – 20.5)


Nagaland


Kiphire

Zunheboto


Baseline

% (95% CI)

Follow-up

% (95% CI)

Baseline

% (95% CI)

Follow-up

% (95% CI)


Frequency of injecting in the last week

At least once daily

4-6 times a week

2-3 times a week

Only once

Don’t know / remember

43.0 (38.5 – 51.9)

28.0 (22.1 – 32.8)

22.7 (17.3 – 26.4)

5.6 (2.4 – 8.4)

--

28.8 (22.8 – 33.1)

24.6 (18.8 – 29.3)

33.7 (28.7 – 41.8)

12.9 (8.2 – 18.6)

--

36.6 (29.3 – 43.4)

30.6 (24.1 – 36.2)

32.1 (26.4 – 40.2)

0.7 (0.0 – 1.7)

--

26.7 (20.7 – 33.9)

52.0 (45.7 – 59.0)

13.6 (10.6 – 17.8)

7.0 (3.6 – 8.2)

0.7 (0.0 – 1.5)


Did NOT share needles / syringes during past month

85.4 (81.7 – 94.0)

64.1 (59.1 – 68.8)

68.7 (61.6 – 75.1)

72.0 (66.8 – 76.6)


fDid NOT share needles / syringes at last injection

63.3 (18.3 – 87.7)

68.8 (63.7 – 73.5)

45.5 (30.7 – 50.8)

73.8 (68.6 – 78.3)


Drew up drug solutions from a common container at last injection

30.7 (26.8 – 35.1)

46.8 (40.9 – 52.8)

41.3 (35.9 – 45.5)

53.8 (47.9 – 59.1)


Number of female partners had sex with in the past 12 months

None

1

2-3

>3

3.5 (1.9 – 6.0)

45.6 (39.9 – 51.3)

33.2 (27.3 – 38.0)

17.7 (14.6 – 21.3)

0.0 (0.0 – 0.0)

38.1 (24.9 – 36.6)

31.0 (24.9 – 36.6)

30.9 (25.4 – 37.0)

3.7 (1.8 – 5.1)

42.7 (32.8 – 47.1)

27.5 (22.3 – 33.4)

26.1 (23.7 – 34.6)

0.3 (0.0 – 0.06)

54.2 (50.1 – 61.8)

29.7 (24.7 – 36.1)

15.8 (10.2 – 17.3)


Condom use at last sex

Regular partner

Casual partner

47.3 (41.2 – 58.3)

44.6 (36.7 – 57.2)

38.1 (31.1 – 46.2)

73.6 (64.2 – 83.2)

52.4 (47.2 – 61.5)

44.9 (17.1 – 64.6)

33.4 (27.0 – 41.0)

86.0 (73.8 – 90.2)


STI symptoms during past 12 months

9.5 (7.3 – 12.5)

19.4 (15.5 – 23.4)

21.1 (17.2 – 26.0)

11.4 (8.7 – 14.8)


Armstrong et al. BMC Public Health 2011 11(Suppl 6):S9   doi:10.1186/1471-2458-11-S6-S9

Open Data